Printer Friendly

IMRE ANNOUNCES THIRD-QUARTER RESULTS

 IMRE ANNOUNCES THIRD-QUARTER RESULTS
 SEATTLE, Nov. 14 /PRNewswire/ -- IMRE Corp. (NASDAQ: IMRE) today


announced results for the quarter ended Sept. 30, 1991, with product sales for the quarter of $801,153, as compared to $488,965 for the same period in 1990. The company reported a net loss for the quarter of $295,275, or 3 cents per share, as compared to $215,580, or 4 cents per share, for the third quarter of last year. The loss per share reflects the issuance of approximately 5,550,000 shares of common stock in a public offering in September 1991. The increased loss is due primarily to expenditures in marketing and sales to promote the PROSORBA(R) column and expenditures in research and development.
 IMRE Corp. is a Seattle-based medical products company that is a pioneer and the leader in the field of therapeutic extracorporeal immunoadsorption, a process of treating a diseased patient's blood outside the body.
 IMRE CORP.
 CONSOLIDATED FINANCIAL DATA
 (In thousands, except per-share data)
 Three months ended Sept. 30: 1991 1990
 Sales $ 801 $ 489
 Interest income 40 --
 Total revenues 841 489
 Expenses 1,136 705
 Net loss $ 295 $ 216
 Net loss per share $ 0.03 $ 0.04
 -0- 11/14/91
 /CONTACT: Lois Yoshida of IMRE Corp., 206-448-1000/
 (IMRE) CO: IMRE Corp. ST: Washington IN: MTC SU: ERN SC-LA -- SE003 -- 4283 11/14/91 09:10 EST
COPYRIGHT 1991 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1991 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Nov 14, 1991
Words:229
Previous Article:NORFOLK SOUTHERN EXPECTS SPECIAL CHARGE TO FOURTH QUARTER EARNINGS AND CONSIDERS CURRENT SHARE PURCHASE PROGRAM SUSPENSION
Next Article:ANAREN ANNOUNCES FIRST QUARTER EARNINGS
Topics:


Related Articles
IMRE CORP. ANNOUNCES SEPARATION OF WARRANTS FROM UNITS
IMRE REPORTS RESULTS
IMRE CORPORATION ANNOUNCES THIRD QUARTER RESULTS
IMRE CORP. ANNOUNCES THIRD QUARTER RESULTS; QUARTERLY SALES OF PROSORBA COLUMN REACH $2,000,000 FOR THE FIRST TIME
IMRE AND BAXTER SIGN DISTRIBUTION AGREEMENT

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters